BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32090253)

  • 1. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
    Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.
    Manner H; Pech O; Heldmann Y; May A; Pauthner M; Lorenz D; Fisseler-Eckhoff A; Stolte M; Vieth M; Ell C
    Surg Endosc; 2015 Jul; 29(7):1888-96. PubMed ID: 25294553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
    Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
    Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
    BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagectomy versus observation following endoscopic submucosal dissection of pT1b esophageal adenocarcinoma.
    Tankel J; Ijner T; Ferri C; Trottenberg T; Dehghani M; Najmeh S; Fiset PO; Alsaddah S; Cools-Lartigue J; Spicer J; Mueller C; Ferri L
    Surg Endosc; 2024 Mar; 38(3):1342-1350. PubMed ID: 38114878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
    Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
    Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
    Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH
    J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.
    Boys JA; Worrell SG; Chandrasoma P; Vallone JG; Maru DM; Zhang L; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Molena D; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):6-12; discussion 12. PubMed ID: 26408330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
    Trivedi A; Cartun RW; Ligato S
    Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.
    van de Ven SEM; Suzuki L; Gotink AW; Ten Kate FJC; Nieboer D; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Curvers W; van Lijnschoten IG; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
    United European Gastroenterol J; 2021 Nov; 9(9):1066-1073. PubMed ID: 34609076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancers.
    Kim H; Kim JH; Park JC; Lee YC; Noh SH; Kim H
    Oncol Rep; 2011 Jun; 25(6):1589-95. PubMed ID: 21455589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
    J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.